Outcomes of patients with myelodysplatic syndrome and chronic myelomonocytic leukemia post clofarabine failure

BACKGROUND: The outcome of patients with myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML) post clofarabine is unknown. METHODS: We reviewed 109 patients with MDS or CMML with a median age of 67 years, treated with a clofarabine-based chemotherapy as frontline (n = 38) or sal...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Ghanem, Hady, Garcia-Manero, Guillermo, Faderl, Stefan, Ravandi, Farhad, Cortes, Jorge, Katragadda, Lakshmikanth, O’Brien, Susan, Daver, Naval, Pierce, Sherry, Kadia, Tapan, Kantarjian, Hagop, Jabbour, Elias
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2014
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3949300/
https://ncbi.nlm.nih.gov/pubmed/24688752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620713519742
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items